Joanna C. Masters, Akash Khandelwal, Alessandra diPietro, Haiqing Dai, & Satjit Brar. (2022). Model‐informed drug development supporting the approval of the avelumab flat‐dose regimen in patients with advanced renal cell carcinoma. Wiley.
Chicago Style (17th ed.) CitationJoanna C. Masters, Akash Khandelwal, Alessandra diPietro, Haiqing Dai, and Satjit Brar. Model‐informed Drug Development Supporting the Approval of the Avelumab Flat‐dose Regimen in Patients with Advanced Renal Cell Carcinoma. Wiley, 2022.
MLA (9th ed.) CitationJoanna C. Masters, et al. Model‐informed Drug Development Supporting the Approval of the Avelumab Flat‐dose Regimen in Patients with Advanced Renal Cell Carcinoma. Wiley, 2022.
Warning: These citations may not always be 100% accurate.